Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background: Myostatin negatively regulates skeletal muscle growth. Myostatin knockout mice exhibit muscle hypertrophy and decreased interstitial fibrosis. We investigated whether a plasmid expressing a short hairpin interfering RNA (shRNA) against myostatin and transduced using electroporation would increase local skeletal muscle mass. Methods: Short interfering RNAs (siRNAs) targeting myostatin were co‐transfected with a myostatin‐expressing plasmid into HEK293 cells and identified for myostatin silencing by Western blot. Corresponding shRNAs were cloned into plasmid shRNA expression vectors. Myostatin or a randomer negative control shRNA plasmid was injected and electroporated into the tibialis anterior or its contralateral muscle, respectively, of nine rats that were sacrificed after 2 weeks. Six other rats received a β‐galactosidase reporter plasmid and were sacrificed at 1, 2, and 4 weeks. Uptake of plasmid was examined by β‐galactosidase expression, whereas myostatin expression was determined by real‐time polymerase chain reaction (PCR) and Western blotting. Muscle fiber size was determined by histochemistry. Satellite cell proliferation was determined by PAX7 immunohistochemistry. Myosin heavy chain type II (MHCII) expression was determined by Western blot. Results: β‐Galactosidase reporter plasmid was expressed at 1 and 2 weeks but diminished by 4 weeks in tibialis anterior skeletal muscle. Myostatin shRNA reduced myostatin mRNA and protein expression by 27 and 48%, respectively. Tibialis anterior weight, fiber size, and MHCII increased by 10, 34, and 38%, respectively. Satellite cell number was increased by over 2‐fold. Conclusions: This is the first demonstration that myostatin shRNA gene transfer is a potential strategy to increase muscle mass. Copyright © 2006 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039 · cited 1×
“KO mouse model and in the naturally occurring bovine mutant cattle breeds (Belgian Blue, Piedmontese, and others), loss of myostatin activity increased muscle mass [1,8].”
BackgroundMyostatin Mutation Associated with Gross Muscle Hypertrophy in a Child
Schuelke, M., Wagner, K. R., Stolz, L. E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J. F., & Lee, S.-J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040933 · Cited by 1,399
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014 · cited 2×
“Myostatin is known to control the number of myofibers during fetal skeletal muscle development, but in adult skeletal muscle growth, it may act by simply controlling the proliferation of satellite cells, as has been shown in vitro [2,3,5,6,42].”
BackgroundThe Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008 · cited 1×
“The potential benefit of myostatin shRNA gene therapy lies in the treatment of the loss of skeletal muscle in conditions such as sarcopenia of old age [47], muscular dystrophies [16], muscle atrophy in space flight [48] or prolonged inactivity [49], and muscle wasting such as cachexia and HIV infection prior to the ad…”
BackgroundFunctional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831 · cited 3×
“against myostatin [16] or by crossing this mouse with”
BackgroundREGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819 · cited 1×
“Myostatin is known to control the number of myofibers during fetal skeletal muscle development, but in adult skeletal muscle growth, it may act by simply controlling the proliferation of satellite cells, as has been shown in vitro [2,3,5,6,42].”
BackgroundGonzalez-Cadavid, N. F., Taylor, W. E., Yarasheski, K., Sinha-Hikim, I., Ma, K., Ezzat, S., Shen, R., Lalani, R., Asa, S., Mamita, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14938 · Cited by 571 · cited 1×
“The potential benefit of myostatin shRNA gene therapy lies in the treatment of the loss of skeletal muscle in conditions such as sarcopenia of old age [47], muscular dystrophies [16], muscle atrophy in space flight [48] or prolonged inactivity [49], and muscle wasting such as cachexia and HIV infection prior to the ad…”
BackgroundLiu, M., Yue, Y., Harper, S. Q., Grange, R. W., Chamberlain, J. S., & Duan, D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.013 · Cited by 178
Cited by
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J. C., Hadj Sassi, A., Seiliez, I., Picard, B., & Bonnieu, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1689-x · Cited by 397
“Similarly, injection of myostatin shRNAs in rats increases the number of satellite cells by over twofold [53].”
BackgroundTargeted ablation of beta cells in the embryonic zebrafish pancreas using E. coli nitroreductase
Pisharath, H., Rhee, J. M., Swanson, M. A., Leach, S. D., & Parsons, M. J. (2007) · Mechanisms of Development · doi:10.1016/j.mod.2006.11.005 · Cited by 373
Amirouche, A., Durieux, A.-C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X., Peinnequin, A., & Freyssenet, D. (2009) · Endocrinology · doi:10.1210/en.2008-0959 · Cited by 282
TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator
Tsai, V. W.-W., Macia, L., Johnen, H., Kuffner, T., Manadhar, R., Jørgensen, S. B., Lee-Ng, K. K. M., Zhang, H. P., Wu, L., Marquis, C. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055174 · Cited by 188
“Additionally, in mouse knockout models, growth differentiation factor 3 (GDF3) deficient mice displayed increased basal metabolic rate, and myostatin deficient mice displayed decreased skeletal muscle mass with increased adiposity [40–42], which contrasted to what female MIC-1 exhibited, suggesting a novel role of MIC…”
BackgroundGonzalez-Cadavid, N. F. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01195.x · Cited by 172
Metadata
- Authors
- Magee, T. R., Artaza, J. N., Ferrini, M. G., Vernet, D., Zuniga, F. I., Cantini, L., Reisz‐Porszasz, S., Rajfer, J., & Gonzalez‐Cadavid, N. F.
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2006-06-29
- Volume
- 8
- Issue
- 9
- Pages
- 1171-1181
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W1974310129
- Cited by
- 106
- References
- 10
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. https://app.cochat.ai/papers/10.1002/jgm.946
- The paper
- Magee, T. R., Artaza, J. N., Ferrini, M. G., Vernet, D., Zuniga, F. I., Cantini, L., Reisz‐Porszasz, S., Rajfer, J., & Gonzalez‐Cadavid, N. F. (2006). Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.946
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.